Maxime Dely: Trends in Red Blood Cell Consumption in France
Maxime Dely, Sales and Application Specialist in Therapeutic Apheresis and Cell Therapy, shared a post on LinkedIn:
“Trends in Red Blood Cell (RBC) consumption in France
- A steady decline over the past decade
Over the last ten years, a clear trend has emerged: overall RBC consumption in France has been steadily decreasing.
This evolution is largely driven by major advances in medical and surgical practices. Procedures are now more targeted and minimally invasive, with better anticipation of bleeding risks.
At the same time, transfusion best practices have evolved significantly: the goal is no longer to transfuse more, but to transfuse appropriately, avoiding unnecessary over-transfusion.
- Fewer standard RBC units, but more relevant transfusion strategies.
- A significant shift in the nature of transfusion needs
This overall decline does not mean that transfusion challenges are disappearing. On the contrary, the profile of needs is changing.
In France, a genetic disease remains highly prevalent: sickle cell disease.
These patients often require regular red blood cell exchange transfusions, frequently performed through erythrocytapheresis, and depend on RBC units with rare blood group phenotypes.
- A dual dynamic to consider
We are now facing a clear correlation: a decrease in standard RBC consumption, alongside an increase in demand for highly specific and rare RBC units.
- A direct impact on donor recruitment strategies
This shift is profoundly reshaping donor recruitment and communication strategies.
Where “standard” donor profiles were largely sufficient 10–15 years ago, there is now a growing need for targeted outreach, focused on donors with rare blood groups.
- Transfusion medicine is evolving.
- Blood donor recruitment must evolve with it.”

Find more posts featuring Maxime Dely on Hemostasis Today.
-
Nov 12, 2026, 22:52Milka Koupenova: The Role of Platelet RIG-I in Regulating Thrombotic Responses
-
Nov 12, 2026, 22:50Arun V J: Why Has India Still Not Achieved 100% Voluntary Blood Donation?
-
Nov 12, 2026, 22:49Sickle Cell Disease Deserves to Be Prioritised in Ghana – ISCC
-
Nov 12, 2026, 22:47Samir Kumar Beura: Delighted to Serve as a Topic Editor for a Research Topic in Frontiers in Neuroscience
-
Nov 12, 2026, 22:46Ashish Sharma: In-Hospital Mortality and Bleeding Complications in APL
-
Nov 12, 2026, 22:44Mary Cushman: New Position at the Vermont Center for Cardiovascular and Brain Health
-
Nov 12, 2026, 22:43Lama Alstanbuli: Discussing and Optimizing Stroke Pathways Across Healthcare Systems
-
Nov 12, 2026, 22:35Carmen’s Recovery From Spontaneous Coronary Artery Dissection – American Heart Association
-
Nov 12, 2026, 22:34What’s Next in Comprehensive Care for Hemophilia and Other Bleeding Disorders? – WFH